It's been a good earnings season for upside surprises so far — and Morgan Stanley says there are more on the horizon.

FormBlends, a telehealth platform focused on medically supervised GLP-1 therapy and peptide research, today released its 2026 ...

Financing led by Sofinnova Investments and co-led by Forbion and Novo HoldingsProceeds to advance lead immunology program COL-5671, a potential ...

Q1 2026 adjusted EPS* above the high end of our guidance range; Raising 2026 annual outlook (All amounts in U.S. dollars)TORONTO, April 27, 2026 ...

As regulatory deadlines loom, this bill is widely regarded as a pivotal turning point poised to reshape the developmental ...

PALSONIFY is the first once-daily, oral therapy approved to treat acromegaly in the European UnionApproval based on strength of data from two ...

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- AriseAlpha officially launched its new free AI Day Trading Bot , designed ...

The Company will be hosting a conference call to discuss the results on Thursday, May 14, 2026. Conference call details are as follows: ...

Austin, Texas, United States, April 27th, 2026, FinanceWireDatavault AI (NASDAQ: DVLT) announced it has executed a ...

POET Technologies Inc. ("POET" or the "Company") (NASDAQ: POET), a leader in the design and implementation of highly-integrated optical engines and light sources for artificial intelligence networks, ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with ...

Investors and security holders will be able to obtain free copies of the registration statement, the joint proxy statement/prospectus and all other relevant documents filed or that will be filed with ...